Maiwald Magazine

Press Articles

15 Apr 2025 - Pressebericht

Cyprumed Enters License and Option Agreement with MSD for the Development of Oral Peptide Therapeutics

Cyprumed GmbH and Merck & Co., Inc. have entered a Non-Exclusive License and Option Agreement to develop oral formulations of peptides using Cyprumed’s drug delivery technology. MSD gains global non-exclusive rights...

2 Apr 2025 - Pressebericht

Managing IP names Maiwald one of the leading IP law firms in Germany

The market analysis by Managing IP and the IP STARS ranking 2024 confirm this: The German market for intellectual property remains dynamic and highly competitive. Especially in the field of patent law, numerous law firms were able to maintain and expand their leading positio...

25 Mar 2025 - Pressemitteilung

Roche gets Illumina unit’s DNA testing patent revoked

A European Patent Office board of appeal said in a ruling published on March 10th that Roche Diagnostics GmbH proved Verinata Health Inc.'s blueprint lacks an inventive step over an earlier international patent application setting out a similar way of testing "free-floating ...

Maiwald in the press

11 Jun 2025 - Publikation

Managing IP Awards interview: Maiwald
ManagingIP June 10, 2025

In their recent feature with Managing IP, senior representatives from Maiwald – Dr. Anja Fux, Dr. Derk Vos, Heike Roeder-Hitschke, Dr. Nils Braun and Martina Boidol...

30 Apr 2025 - Publikation

Safe Harbor Provision in European Patent LawThe Research & Bolar Exemptions, AIPLA Chemical Practice Chronicles Newsletter, Volume 13 Issue 1 2025

This article covers the most recent developments regarding the European Research Exemption, which permits the use of patented inventions for research purposes, as well as the ...

30 Apr 2025 - Publikation

The ‘long-arm’ of the Unified Patent Court – New developments in European cross-border patent litigation, AIPLA Chemical Practice Chronicles Newsletter, Volume 13 Issue 1 2025

The jurisdictional reach of the Unified Patent Court (UPC) was a widely and controversially discussed topic from the outset. Some practitioners took the view that the UPC also...

Events

Wed.

21 May 2025 |Past Event|Externe Veranstaltungen

C5’s 18th Annual Forum on “Pharma & Biotech Patent Litigation in Europe” in Amsterdam

We are pleased that Dr. Eva Susanne Ehlich was an expert at the 18th C5 Communications Forum on “Pharma & Biotech Patent Litigation in Europe” in Amsterdam. Eva gave a presentation on “Plausibility and Post-Publication Evidence in Inventi...

Tue.

20 May 2025 |Past Event|Vortag Live

Joint symposium with Oblon in Tokyo on May 20, 2025

The The Oblon and Maiwald firms were pleased to host a complimentary joint international symposium on: U.S. and European Patent Practice: Important Aspects for Practitioners At the 2025 joint symposium, selected current aspects of protecting innovations in the U.S. and Europe were examined, considering b...

Sat.

17 May 2025 |Past Event|Externe Veranstaltungen

Maiwald at INTA’s 2025 Annual Meeting in San Diego

The International Trademark Association's (INTA) Annual Meeting took place in San Diego from May 17 to 21 this year. Maiwald was among the many companies and law firms in attendance, represented by Susanna Heurung,

Thu.

15 May 2025 |Past Event|Seminar

Maiwald Seminar on May 15

Patent law news: EPO case law, software and UPC (Lectures will be held in German) On May 15, we had the pleasure of hosting another Maiwald seminar in our office. Thank you to the speakers and everyone involved for making this an interesting afternoon and ensuring the event ran smoothly.

All events

News and Releases

Maiwald Blog

Turn one into several – what Rule 80 EPC says about using several independent claims to defend one independent claim

EPO Board of Appeal 3.3.04 is setting the right standard for acknowledging novelty of non-medical use claims (T 1913/21)

EPO revokes Roche’s Patent on combination therapy of bevacizumab and paclitaxel for platinum-resistant ovarian cancer that was supported by results of Phase III AURELIA clinical trial

Press Articles

Cyprumed Enters License and Option Agreement with MSD for the Development of Oral Peptide Therapeutics

Managing IP names Maiwald one of the leading IP law firms in Germany

Roche gets Illumina unit’s DNA testing patent revoked

Staff News

Maiwald congratulates Dr. Anna Closs on passing the exam

Maiwald appoints Dr. Lukas Delvos and Dr. Jian Sun as Counsel

Maiwald congratulates on passing the exam

Managing IP Awards interview: Maiwald
ManagingIP June 10, 2025

Safe Harbor Provision in European Patent LawThe Research & Bolar Exemptions, AIPLA Chemical Practice Chronicles Newsletter, Volume 13 Issue 1 2025

The ‘long-arm’ of the Unified Patent Court – New developments in European cross-border patent litigation, AIPLA Chemical Practice Chronicles Newsletter, Volume 13 Issue 1 2025

Awards

Dr. Marco Stief honoured as Thought Leader Germany, Lexology Index 2025

Leaders League Ranking Germany 2025

Maiwald honoured by Managing IP for more than ten years

Events

C5’s 18th Annual Forum on “Pharma & Biotech Patent Litigation in Europe” in Amsterdam

Joint symposium with Oblon in Tokyo on May 20, 2025

Maiwald at INTA’s 2025 Annual Meeting in San Diego

Maiwald Seminar on May 15